We are proud to announce that Maude Robitaille has been honored with the Relève étoile Louis‑Berlinguet award in the Nature and Technology sector from the Fonds de recherche du Québec – Nature et technologies (FRQNT). This prestigious monthly award recognizes exceptional contributions by emerging researchers in Quebec.
Maude’s award-winning paper, titled “169Yb‑based high dose rate intensity modulated brachytherapy for focal treatment of prostate cancer”, was published in Brachytherapy. The work explores a novel approach using Ytterbium‑169 (¹⁶⁹Yb) instead of the conventional Iridium‑192, aiming to deliver precise, less invasive treatment plans for prostate cancer while potentially reducing the number of catheters needed
